Featured Research

from universities, journals, and other organizations

Animal studies show progress in vaccine against human leishmaniasis

Date:
December 3, 2013
Source:
Investigación y Desarrollo
Summary:
Human leishmaniasis is considered endemic in the south states of Mexico. Mexican researchers have now developed a vaccine against this disease, as tested in animals

Leishmaniasis is an ailment transmitted through insects very similar to mosquitos and mainly presents symptoms in the skin, liver or spleen.
Credit: Investigación y Desarrollo

A research executed in the Autonomous University of Yucatan (UADY) has successfully proved, in test animals, the effectiveness of a vaccine that immunizes the organism against leishmaniasis, an ailment transmitted through insects very similar to mosquitos and mainly presents symptoms in the skin, liver or spleen.

Related Articles


Head of the project, Eric Dumonteil, says that this research represents an important leap forward in the fight against a disease that causes 70 thousand deaths a year in developing countries.

To create the immunizer, researchers isolated the genes of the protozoon responsible of causing leishmaniasis, using a molecular biology technique to code the proteins responsible of the protective response in vaccinated individuals.

Dumonteil pointed out that this pathogen hides within the cells of the immune system getting to manipulate and avoid it without being eradicated using conventional techniques.

The project was accomplished in the Parasitology Lab from the Center of Regional Research "Dr. Hideyo Noguchi" where the genetically created vaccine was subcutaneously administered to mice.

The results allowed to observe that after four weeks the rodents have already developed antibodies and, after 8 weeks, the cellular immune response and the production of defensive substances were present in great quantity.

Four weeks after the dose, the researchers infected mice with the parasite responsible of transmitting leishmaniasis and observed a survival of 80 per cent of the experimental group.

The clinic manifestations of the disease vary from mild skin lessions to intestinal complications that can end the life of the patient. In Mexico, the southeast region is where most of the cases of leishmaniasis have been registered, were the disease is considered endemic.

Currently, the research group is testing dogs, which also are reservoir of the parasite and the presence of infected canines in a determined are can make people to suffer the disease more frequently.

Dumonteil from the Parasitology Laboratory highlighted that the possibility of a technological transference to a lab that allows to transfer the results of this research to a clinical praxis is being considered, as well as increasing the efficiency of the strategy with immune response boost drugs.


Story Source:

The above story is based on materials provided by Investigación y Desarrollo. Note: Materials may be edited for content and length.


Cite This Page:

Investigación y Desarrollo. "Animal studies show progress in vaccine against human leishmaniasis." ScienceDaily. ScienceDaily, 3 December 2013. <www.sciencedaily.com/releases/2013/12/131203090653.htm>.
Investigación y Desarrollo. (2013, December 3). Animal studies show progress in vaccine against human leishmaniasis. ScienceDaily. Retrieved April 22, 2015 from www.sciencedaily.com/releases/2013/12/131203090653.htm
Investigación y Desarrollo. "Animal studies show progress in vaccine against human leishmaniasis." ScienceDaily. www.sciencedaily.com/releases/2013/12/131203090653.htm (accessed April 22, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Wednesday, April 22, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Teva Offers $40 Billion for Mylan

Teva Offers $40 Billion for Mylan

Reuters - Business Video Online (Apr. 21, 2015) — Generic drugmaker Teva Pharmaceutical is offering $82 a share, or $40 billion, for its smaller rival Mylan, in an alternative to Mylan&apos;s deal to buy Perrigo. Bobbi Rebell reports. Video provided by Reuters
Powered by NewsLook.com
Blue Bell Recalls All Products

Blue Bell Recalls All Products

AP (Apr. 21, 2015) — Blue Bell Creameries voluntary recalled for all of its products after two samples of chocolate chip cookie dough ice cream tested positive for listeria, a potentially deadly bacteria. Blue Bell&apos;s President and CEO issued a video statement. (April 21) Video provided by AP
Powered by NewsLook.com
Yemen Doctors at Breaking Point

Yemen Doctors at Breaking Point

Reuters - News Video Online (Apr. 21, 2015) — A Sanaa hospital struggles to cope with the high number of casualties with severe injuries, after an air strike left at least 25 dead and hundreds wounded. Deborah Lutterbeck reports. Video provided by Reuters
Powered by NewsLook.com
'Tutu Tuesdays' Brighten Faces at Kids' Hospital

'Tutu Tuesdays' Brighten Faces at Kids' Hospital

AP (Apr. 21, 2015) — Doctors and nurses have started wearing ballet tutus every Tuesday to cheer up young hospital patients at a Florida hospital. It started with a request made by a nervous patient -- now, almost the entire staff is wearing the tutus. (April 21) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins